Related Experiment Video
Updated: Jul 30, 2025

07:27
Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
24.7K
Inappropriate Implantable Cardioverter-Defibrillator Therapy During Total Hip Arthroplasty
Alexander M DeLeon1, Rachael Lu1, Liting Chen1
1Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago, USA.
Cureus
|May 17, 2023
Summary
Electromagnetic interference (EMI) can cause inappropriate therapy from implantable cardioverter-defibrillators (ICDs). Even below-umbilical surgery with electrocautery may pose risks, necessitating careful consideration of device management.
Area of Science:
- Cardiology
- Medical Devices
- Surgical Electrophysiology
Background:
- Electromagnetic interference (EMI) poses a risk for inappropriate therapy from implantable cardioverter-defibrillators (ICDs).
- Current guidelines suggest infraumbilical surgeries using monopolar electrocautery are low risk for EMI, often not requiring routine magnet application.
- Patient history and surgical factors can influence EMI susceptibility.
Observation:
- A 71-year-old woman with an ICD for non-ischemic cardiomyopathy underwent a left total hip arthroplasty.
- Monopolar electrocautery was utilized for the infraumbilical surgery.
- The patient experienced nine episodes of inappropriate ICD therapy during the procedure.
Findings:
- Despite infraumbilical surgery, significant EMI occurred, leading to multiple inappropriate ICD therapies.
- The placement of the electrocautery dispersion pad is hypothesized to be a contributing factor.
- No long-term sequelae were observed in the patient.
Implications:
- The location of electrocautery dispersion pads should be carefully considered during infraumbilical surgeries in patients with ICDs.
- Suspending anti-tachycardia functions intraoperatively may be necessary even when guidelines do not mandate it.
- This case highlights the need for individualized risk assessment regarding EMI and ICDs.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
19
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
19
Heart Failure VI: Adjunct Therapies
18
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
18
Cardiac Catheterization IV: Nursing Management
80
Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
80

